Intrarenal angiotensin II is associated with inflammation, renal damage, and dysfunction in Dahl salt-sensitive hypertension

Journal of the American Society of Hypertension

Volumn 3, Issue 5, 2009, Pages 306-314

  Lin, Lin ^a   Phillips, William E ^a   Manning Jr , R Davis ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

cytokines; macrophages; Renal failure; renal hemodynamics

Indexed keywords

ANGIOTENSIN II; CANDESARTAN HEXETIL; CHEMOKINE; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY CATHETER; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE CLEARANCE; DAHL SALT SENSITIVE RAT; DRUG MECHANISM; GLOMERULUS; HIGH SODIUM INTAKE; HORMONE ACTION; HYPERTENSION; IMMUNOCOMPETENT CELL; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; MACROPHAGE; MALE; MONOCYTE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RISK REDUCTION; TISSUE LEVEL; URINARY EXCRETION;

EID: 70349768250     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2009.08.002     Document Type: Article

References (33)

1. Iwai J., Dahl L.K., and Knudsen K.D. Genetic influence on the renin-angiotensin system: low-renin activities in hypertension-prone rats. Circ Res 32 (1973) 678-684
2. Nishiyama A., Yoshizumi M., Rahman M., Kobori H., Seth D.M., Miyatake A., et al. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int 65 (2004) 972-981
3. Otsuka F., Yamauchi T., Kataoka H., Mimura Y., Ogura T., and Makino H. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in Dahl salt-sensitive rats. Am J Physiol 274 (1998) R1797-R1806
4. Franco M., Martinez F., Rodriguez-Iturbe B., Johnson R.J., Santamaria J., Montoya A., et al. Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension. Am J Physiol Renal Physiol 291 (2006) F1281-F1287
5. Gonzalez-Villalobos R.A., Seth D.M., Satou R., Horton H., Ohashi N., Miyata K., et al. Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol 295 (2008) F772-F779
6. Kobori H., Nishiyama A., Abe Y., and Navar L.G. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high-salt diet. Hypertension 41 (2003) 592-597
7. Hayakawa H., Coffee K., and Raij L. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy. Circulation 96 (1997) 2407-2413
8. Kodama K., Adachi H., and Sonoda J. Beneficial effects of long-term enalapril treatment and low-salt intake on survival rate of Dahl salt-sensitive rats with established hypertension. J Pharmacol Exp Ther 283 (1997) 625-629
9. Chandramohan G., Bai Y., Norris K., Rodriguez-Iturbe B., and Vaziri N.D. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1, and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Am J Nephrol 28 (2008) 158-167
10. Kobori H., Nangaku M., Navar L.G., and Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59 (2007) 251-287
11. Tian N., Moore R.S., Phillips W.E., Lin L., Braddy S., Pryor J.S., et al. NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 295 (2008) R1858-R1865
12. Ozawa Y., Kobori H., Suzaki Y., and Navar L.G. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 292 (2007) F330-F339
13. Mattson D.L., James L., Berdan E.A., and Meister C.J. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48 (2006) 149-156
14. Tian N., Gu J.W., Jordan S., Rose R.A., Hughson M.D., and Manning Jr. R.D. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 292 (2007) H1018-H1025
15. Meng S., Roberts L.J., Cason G.W., Curry T.S., and Manning Jr. R.D. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 283 (2002) R732-R738
16. Tian N., Thrasher K.D., Gundy P.D., Hughson M.D., and Manning Jr. R.D. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 45 (2005) 934-939
17. Tian N., Rose R.A., Jordan S., Dwyer T.M., Hughson M.D., and Manning Jr. R.D. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 24 (2006) 2263-2270
18. Jones D.P. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 348 (2002) 93-112
19. Tian N., Moore R.S., Braddy S., Rose R.A., Gu J.W., Hughson M.D., et al. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 293 (2007) H3388-H3395
20. Chandramohan G., Bai Y., Norris K., Rodriguez-Iturbe B., and Vaziri N.D. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Am J Nephrol 28 (2008) 158-167
21. Zhou M.S., Adam A.G., Jaimes E.A., and Raij L. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension 42 (2003) 945-951
22. Jaimes E.A., Zhou M.S., Pearse D.D., Puzis L., and Raij L. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. Am J Physiol Renal Physiol 294 (2008) F385-F392
23. Kobori H., Prieto-Carrasquero M.C., Ozawa Y., and Navar L.G. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43 (2004) 1126-1132
24. Zhuo J.L., Imig J.D., Hammond T.G., Orengo S., Benes E., and Navar L.G. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 39 (2002) 116-121
25. Prieto-Carrasquero M.C., Kobori H., Ozawa Y., Gutierrez A., Seth D., and Navar L.G. AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol 289 (2005) F632-F637
26. Rodriguez-Iturbe B., Vaziri N.D., Herrera-Acosta J., and Johnson R.J. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286 (2004) F606-F616
27. Alvarez V., Quiroz Y., Nava M., Pons H., and Rodriguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 283 (2002) F1132-F1141
28. Beswick R.A., Zhang H., Marable D., Catravas J.D., Hill W.D., and Webb R.C. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37 (2001) 781-786
29. Franco M., Tapia E., Santamaria J., Zafra I., Garcia-Torres R., Gordon K.L., et al. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure. J Am Soc Nephrol 12 (2001) 2263-2271
30. Quiroz Y., Pons H., Gordon K.L., Rincon J., Chavez M., Parra G., et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 281 (2001) F38-F47
31. Kobori H., Ozawa Y., Suzaki Y., and Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 16 (2005) 2073-2080
32. Mitch W.E., Walser M., Buffington G.A., and Lemann Jr. J. A simple method of estimating progression of chronic renal failure. Lancet 2 (1976) 1326-1328
33. Gansevoort R.T., Sluiter W.J., Hemmelder M.H., de Zeeuw D., and De Jong P.E. Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 10 (1995) 1963-1974